<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03852004</url>
  </required_header>
  <id_info>
    <org_study_id>HYPOSTEO</org_study_id>
    <nct_id>NCT03852004</nct_id>
  </id_info>
  <brief_title>Osteopathic Treatment on Motor Development of Hypotonic Infants.</brief_title>
  <acronym>HYPOSTEO</acronym>
  <official_title>Comparison of Osteopathic Treatment Versus Simulation on Motor Development of Hypotonic Infants.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Intercommunal Creteil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Broussais</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Intercommunal Creteil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional study involving the human at risk and minimal constraint (RIPH2), randomized
      single-blind comparing the impact of osteopathic treatment on the axial tone of the hypotonic
      infant versus simulation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children referred to the &quot;Center Broussais&quot; clinic for hypotonia are evaluated in terms of
      psychomotor development by a pediatrician competent in neuro-pediatrics. It is a cabinet for
      the care of children from 0 to 16 years.

      Osteopaths and pediatricians work together in this office of which 50% are children with
      neurological disorders.

      If osteopathic care is indicated, and for children with inclusion / non-inclusion criteria,
      the study will be offered to parents. In case of parental acceptance, children will be
      randomized in single blind to receive either an osteopathic treatment (osteo group) or a
      simulation (simulation group). Neither the parents nor the pediatrician will know the
      randomization group.

      The osteopathic treatment or simulation will be performed in a standardized way according to
      a previously established protocol.

      In both groups, a neurological evaluation of the axial tone will be performed by a
      pediatrician before randomization, at the end of the first consultation and at the end of the
      3rd consultation, ie 3 consultations by a pediatrician.

      If the child was drawn in the &quot;simulation&quot; group, three additional consultations will be
      offered at the end of the study to allow him to benefit from optimal osteopathic care
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2018</start_date>
  <completion_date type="Anticipated">March 21, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 21, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>simulated osteopathic treatment</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Motor development on the Denver II scale</measure>
    <time_frame>at month 6</time_frame>
    <description>Comparison of the difference between chronological age (in corrected age) and motor development age on the Denver II motor scale in the 2 groups after 3 osteopathy consultations or simulation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Motor development on the Denver II scale</measure>
    <time_frame>at month 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor development on the Denver II scale</measure>
    <time_frame>at month 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction visual scale (from 0 to 10)</measure>
    <time_frame>at month 6</time_frame>
    <description>comparison of parents satisfaction with a visual analogic scale in the 2 groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hypotonia</condition>
  <arm_group>
    <arm_group_label>Osteopatic treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An osteopatic treatment will be realised by osteopath</description>
  </arm_group>
  <arm_group>
    <arm_group_label>simulated osteopathic treatment</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A simulated ostepathic treatment will be realised by osteopath</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ostheopathy</intervention_name>
    <description>standardized osteopathic treatment</description>
    <arm_group_label>Osteopatic treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>simulated osteopathic treatment</intervention_name>
    <description>standardized simulated osteopathic treatment</description>
    <arm_group_label>simulated osteopathic treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:Age: 8 months-24 months corrected age Axial hypotonia in the
        neurological examination

          -  Age (age corrected for prematurity) of motor development evaluated on the Denver II
             scale below chronological age

          -  Proposal for osteopathic treatment by the pediatrician or treating physician

        Exclusion Criteria:

          -  â€¢ Fever, shock or recent fall (face, skull, spine) not medically investigated,
             persistent cyanosis, bulging or depressed fontanel, cervical stiffness, fever

               -  Neuromuscular diseases

               -  Not affiliated to a social security scheme

               -  Refusal to participate in the study by parents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Months</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>camille JUNG, MDPhD</last_name>
    <phone>157022268</phone>
    <phone_ext>+33</phone_ext>
    <email>camille.jung@chicreteil.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roselyne LALAUZE-POL</last_name>
    <phone>140540578</phone>
    <phone_ext>+33</phone_ext>
    <email>r.lalauze@wanadoo.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Broussais</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Romanello, MD</last_name>
      <phone>140540578</phone>
      <phone_ext>+33</phone_ext>
      <email>silviaromanello@yahoo.it</email>
    </contact>
    <contact_backup>
      <last_name>Yannick Aujard, MD PhD</last_name>
      <phone>140032000</phone>
      <phone_ext>+33</phone_ext>
      <email>yannick.aujard@aphp.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 21, 2019</study_first_submitted>
  <study_first_submitted_qc>February 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2019</study_first_posted>
  <last_update_submitted>March 28, 2019</last_update_submitted>
  <last_update_submitted_qc>March 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>osteopathy</keyword>
  <keyword>hypotonia</keyword>
  <keyword>children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Hypotonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

